URODOXA

This brand name is authorized in South Africa

Active ingredients

The drug URODOXA contains one active pharmaceutical ingredient (API):

1 Doxazosin
UNII NW1291F1W8 - DOXAZOSIN

Doxazosin is a potent and selective post-junctional alpha-1-adrenoceptor antagonist. This action results in a decrease in systemic blood pressure.

Read about Doxazosin

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
URODOXA Tablet Health Products Regulatory Authority (ZA) MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C02CA04 Doxazosin C Cardiovascular system → C02 Antihypertensives → C02C Antiadrenergic agents, peripherally acting → C02CA Alpha-adrenoreceptor antagonists
Discover more medicines within C02CA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: ZA Health Products Regulatory Authority Identifier(s): 45/7.1/0150, 45/7.1/0151, 45/7.1/0152, 45/7.1/0153

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.